Cannabix Technologies Inc BLOZF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BLOZF is a good fit for your portfolio.
News
-
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia
-
Breathalyzer Market Booms with Technological Advances; Key to Reducing Alcohol-Related Road Deaths
-
Cannabix’s Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
-
Cannabis Market Flourishes Amid Global Legalization, Driving Concerns About Road Safety
-
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California
-
Breathalyzer Market Expands with Tech Advances and Stricter Alcohol Laws
-
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix
Trading Information
- Previous Close Price
- $0.29
- Day Range
- $0.30–0.37
- 52-Week Range
- $0.12–0.48
- Bid/Ask
- $0.32 / $0.33
- Market Cap
- $36.90 Mil
- Volume/Avg
- 232,684 / 138,920
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Cannabix Technologies Inc is in the development of marijuana breathalyzer. It is developing breath testing technologies that can be used at the point of care to detect recent use of marijuana. It is also developing its technology to help employers, law enforcement, government and the public, when marijuana is becoming legal for recreational and medicinal use in many jurisdictions globally. The FAIMS device is designed to operate both independently or coupled in tandem directly to a mass spectrometer, used in forensic labs. The THC Breath Analyzer is a point of care breath testing tool for the rapid detection of recent cannabis use.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- —
Valuation
|
Metric
|
BLOZF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 8.39 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
BLOZF
|
|---|---|
Quick Ratio | 47.30 |
Current Ratio | 47.80 |
Interest Coverage | — |
Quick Ratio
BLOZF
Profitability
|
Metric
|
BLOZF
|
|---|---|
Return on Assets (Normalized) | −29.76% |
Return on Equity (Normalized) | −132.67% |
Return on Invested Capital (Normalized) | −32.92% |
Return on Assets
BLOZF
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Bjsbllh | Vspdbnj | $183.9 Bil | |
SYK
| Stryker Corp | Pfwjnbmdp | Kbnq | $128.0 Bil | |
MDT
| Medtronic PLC | Lmyhqsxg | Vbsyj | $106.5 Bil | |
BSX
| Boston Scientific Corp | Pshjycdd | Fcvthp | $105.6 Bil | |
EW
| Edwards Lifesciences Corp | Rtsztrhx | Pjmst | $51.0 Bil | |
DXCM
| DexCom Inc | Lyssrlssrj | Jdrb | $50.4 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Qqgrfltjkn | Pgpp | $24.7 Bil | |
PHG
| Koninklijke Philips NV ADR | Tpvqcnjyn | Snqfm | $24.5 Bil | |
ALGN
| Align Technology Inc | Cbvgpldb | Fptgcz | $21.3 Bil | |
PODD
| Insulet Corp | Vcdjtycps | Wzpfgbm | $12.0 Bil |